Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,200
Closed -$374K 48
2023
Q2
$374K Sell
10,200
-2,500
-20% -$97.3K 0.23% 45
2023
Q1
$518K Sell
12,700
-1,000
-7% -$43.2K 0.44% 44
2022
Q4
$702K Sell
13,700
-832
-6% -$39.9K 0.63% 38
2022
Q3
$636K Buy
+14,532
New +$706K 0.61% 41
2019
Q3
Sell
-5,165
Closed -$213K 52
2019
Q2
$213K Sell
5,165
-26
-0.5% -$1.03K 0.28% 52
2019
Q1
$210K Hold
5,191
0.28% 53
2018
Q4
$215K Sell
5,191
-26
-0.5% -$1.08K 0.33% 47
2018
Q3
$218K Buy
+5,217
New +$201K 0.28% 52

Other funds holding PFE

Dennis R. Delaney's PFE Position: Q3 2023 in Review

Dennis R. Delaney sold out of Pfizer (PFE) in Q3 2023, closing a stake of 10,200 shares — an estimated $374K sold.

Dennis R. Delaney first reported a position in PFE in Q3 2018 and held it in 8 quarters. The position peaked at $702K in Q4 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Dennis R. Delaney reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Dennis R. Delaney sold 10,200 Pfizer shares in Q3 2023, an estimated $374K.
  • Dennis R. Delaney first reported a position in Pfizer in Q3 2018 and held it in 8 quarters.
  • Dennis R. Delaney's Pfizer position peaked at $702K in Q4 2022.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Dennis R. Delaney's 13F filing for Q3 2023, filed 14 Nov 2023.